USC study reveals potential new treatment target in the fight against COVID-19
A new study by Keck School of Medicine (KSOM) researchers reveals how therapies targeting a molecular chaperone called GRP78 might offer additional protection against COVID-19 and other coronaviruses that emerge in the future.